<DOC>
	<DOCNO>NCT02331225</DOCNO>
	<brief_summary>Systemic sclerosis ( SSc , also know scleroderma ) disease characterize fibrosis skin organ , inflammation , abnormal endothelial cell line inside vessel . A common deadly complication SSc pulmonary hypertension ( PH ) , abnormal elevation blood pressure within lung blood vessel . Early identification treatment PH important SSc , clinical factor predict patient develop PH acceptable accuracy . A potential marker PH SSc presence increase amount endothelial microparticles ( EMPs ) , substances circulate blood release damage vessel wall endothelial lining . A main goal study investigate difference EMP level SSc patient without PH . The investigator also use human endothelial cell lab environment test whether EMPs isolate SSc patient actually cause damage vessel lining . Lastly , investigator investigate potential benefit medication use transplant , mycophenolate mofetil ( MMF ) . This do causing damage isolate human endothelial cell treat MMF . The main goal portion study see EMP level reduce cell treat MMF . Overall , investigator anticipate follow outcome study : 1 ) use EMP level differentiation patient SSc PH without PH , 2 ) use EMPs understand endothelial damage occur SSc , 3 ) use EMPs help u develop new treatment patient vascular disease .</brief_summary>
	<brief_title>Endothelial Microparticles Systemic Sclerosis Pulmonary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<criteria>For systemic sclerosis subject : Age &gt; 18 year Meet American College Rheumatology criterion systemic sclerosis Chronic kidney disease ( estimate creatinine clearance &lt; 50mL/min ) Uncontrolled hypertension ( diastolic blood pressure &gt; 120mmHg ) Acute coronary syndrome within past 6 month Chronic obstructive pulmonary disease Diabetes mellitus Hemolytic anemia Active tobacco abuse For healthy control subject : Age &gt; 18 year Age sexmatched SSc patient Exclusion criterion : Coronary artery disease Uncontrolled hypertension ( diastolic blood pressure &gt; 120mmHg ) Chronic obstructive pulmonary disease Chronic kidney disease Diabetes mellitus Hemolytic anemia Active tobacco abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>